Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Discover index funds with standout Sharpe ratios over the last ten years and learn how risk-adjusted performance translates into better risk management.
28,172 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Pennymac confirms it will shutter its Franklin, TN office and reduce staff in its consumer direct lending unit, part ...
Vitalik Buterin signals Ethereum’s next rebuild will be a multi-year effort, potentially matching the scope of the hi...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
As Seer gears up for 2025 earnings, investors weigh growth, margins, and risk. This guide breaks down the drivers beh...
Oil prices plummet after a Reuters-style rumor that the G7 may tap 400 million barrels from strategic reserves. Crypt...
Shareholders allege Nvidia hid how much crypto miners boosted gaming GPU sales. The case could reshape disclosures ac...
Cardano’s ADA hovers around 26 cents as large holders bolster their positions. While the token remains down about 70%...
Iran slams U.S. strikes drew an immediate market response, with oil prices edging higher and risk assets tightening a...
A single Magnificent 7 stock is proving steadier than peers as AI demand drives earnings and share gains, challenging...
A meme-focused token from MemeCore dropped roughly 70%, sending its market cap below $1 billion and triggering renewe...
The Trump administration released a 2026 regulatory plan outlining 702 deregulatory actions across agencies, promisin...